SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has climbed to a fresh 52-week high amid anticipation of its Q3 earnings report and continued optimism around BRIUMVIs growth. Traders debate whether the rally reflects earnings expectations and business momentum or buyout and short-covering speculation; a potential acquisition remains unconfirmed.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is under pressure amid approaching midterms, with traders focusing on reports that Trump canceled campaign rallies and on expectations of Democratic gains that could bring greater scrutiny of his administration. Bearish posts dominate, while some bulls argue the selloff could reverse after the election.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

A sharp pullback in ALAB has traders focused on whether it can hold key chart support ahead of earnings, with the report and guidance viewed as a potential catalyst. Bulls call the drop an opportunity amid continued AI data-center demand, while bears point to the stocks rich valuation and concerns about a broader AI-trade slowdown.

Polkadot (DOT) is a cryptocurrency . Polkadot has a current supply of 1,709,841,036.25825711. The last known price of Polkadot is 0.97593633 USD and is up 7.16 over the last 24 hours. It is currently trading on 1075 active market(s) with $102,857,730.92 traded over the last 24 hours. More information can be found at https://polkadot.com.

Polkadot

Polkadot is drawing attention after a prolonged decline pushed DOT below the psychologically important one-dollar level and toward new lows. Traders are split between calling it a demandless, failing project and treating the depressed price as an accumulation opportunity; some cite the proposed dotUSD stablecoin and Polkadot 2.0 developments as longer-term bullish narratives, while recent rebounds have prompted questions about what is driving them.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines results and weaker outlook have focused attention on soaring jet-fuel costs, which are squeezing margins despite strong revenue and travel demand. Traders are divided between concerns about losses and the airlines heavy debt burden, and hopes that lower fuel prices and premium demand could support a recovery.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors approaching FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date, the revised upper-limb data, and recent commercial job postings. Some see FDA flexibility and INOs approval as encouraging signals, while others caution that hiring is not proof of approval and cite the prior AdCom concerns and efficacy debate.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo shares are under pressure after MaxLinear outlined plans to compete in the 1.6T active electrical cable market, which Credo currently dominates. Traders are debating whether the competitive threat is meaningful given Credos incumbent position, while broader weakness in AI and semiconductor stocks and concern about insider selling add to the unease.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Federal cannabis rescheduling is the dominant topic, with traders focused on procedural delays in the DEA process and uncertainty around when a Schedule III decision could arrive. Some see the delays and resulting weakness as an overreaction and a potential buying opportunity, while others are frustrated that the catalyst remains uncertain and has not supported the shares.

Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF

Defiance Daily Target 2x Long MSTR ETF

MSTXs sharp drop is drawing dip-buying and rebound speculation, while bearish traders warn that further weakness in Bitcoin or Strategy (MSTR) could deepen losses. The debate also centers on the funds 2x daily leverage and volatility decay, which can erode returns when held through choppy markets.

Sui (SUI) is a cryptocurrency launched in 2023. Sui has a current supply of 10,000,000,000 with 4,118,270,447.6403894 in circulation. The last known price of Sui is 0.90640557 USD and is up 4.19 over the last 24 hours. It is currently trading on 998 active market(s) with $545,881,218.06 traded over the last 24 hours. More information can be found at https://sui.io/.

SUI is drawing attention amid a volatile rebound, with traders debating whether the move signals renewed altcoin strength or a short-lived bounce. Bullish posts point to broader crypto momentum and adoption narratives such as Tethers tokenization platform, while skeptics cite token unlocks, supply concerns, and weak performance versus other cryptocurrencies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that its Board of Directors has completed a comprehensive review of the Company's business, programs, resources and...

Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS Ultra System for Ventricular Tachycardia at Banner University Medical Center Phoenix

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced highlights from the first patient enrolled in the Companys study evaluating its next-generation vCLAS Ultra Ultra-Low...

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026. Mr. Salmon brings over three decades of global leadership experience in the medical device and...

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30, 2026. Recent Business Highlights: Announced the successful...

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million.
Adagio Medical Holdings (NASDAQ:ADGM) shares increased byread more...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million.
Adagio Medical Holdings (NASDAQ:ADGM) stockread more...

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation...

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS Ventricular Ablation System for the Treatment of Ventricular Tachycardia

Adagio Medical Holdings, Inc (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the submission of its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the...

Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress

Adagio Medical Holdings, Inc (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results...

Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...

This account has been verified as an official ADGM representative.

Verified Account

ADGM

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

Adagio Medical Holdings Inc.

Why Nano-Cap Adagio Medical Saw The Highest Weekly Spurt In Retail Following Among Healthcare Stocks

Equity

Bearish Sentiment

Shares of Adagio Medical Holdings, Inc. (ADGM) experienced a significant surge in retail investor interest last week as they gained over 122%, driven by regulatory approval for a medical device.On Thursday, Adagio said its vCLAS Cryoablation System had been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with structural heart disease.&nbsp;&nbsp;&nbsp;CEO Todd Usen said the regulatory nod marked a significant milestone for Adagio as it validated its proprietary system as a "potentially unique solution for the large, underserved population of patients suffering from ventricular tachycardia.""We are thrilled to be the only technology to be granted Breakthrough Device designation for endocardial treatment of both ischemic and nonischemic structural heart disease patients with sustained monomorphic VT," he added.Adagio said the FDA's decision was partly based on clinical data from Adagio's European CRYOCURE-VT study.The news resulted in Adagio's retail following on Stocktwits jumping by over 64% last week, with message volume flipping to 'extremely high' levels and sentiment surging to 'extremely bullish.'<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/ADGM_sentiment_and_message_volume_weekly_as_of_April_20_png_377c1aa693.webp" alt="ADGM sentiment and message volume weekly as of April 20.png" width="1318" height="316"><figcaption>ADGM sentiment and message volume weekly as of April 20. | source: Stocktwits</figcaption></figure>One user called the stock surge the "best setup for a major squeeze," although Koyfin data showed Adagio has a relatively low short interest of just 0.5%.The free float, however, stands at just over 15 million.<stembedurl>https://stocktwits.com/DaSqueeza/message/612042599</stembedurl>Another believed Adagio would nearly triple on Monday.<stembedurl>https://stocktwits.com/umiy/message/612011651</stembedurl><a href="https://stocktwits.com/symbol/ADGM">Adagio's stock</a> has gained more than 45% this year but is down over 84% in the past 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

The company said the FDA’s nod validates its proprietary system as a "potentially unique solution for the large, underserved population of patients suffering from ventricular tachycardia."

Adagio Medical Leads Weekly Retail Follower Surge Among Healthcare Stocks On Breakthrough Device Approval

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.083
Prev Close	$0.086
Open	$0.091
Dividend Yield	0.00%
50-Day Moving Average	$0.3089
Beta	0.71
Avg. Volume	2.49M
PE Ratio	-0.06

52-Week High	$1.69
52-Week Low	$0.081
Market Capitalization	$2.28M
EPS (Annual)	-$1.51
Price to Book	-4.44
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

ADGM Fundamentals